[Tryptophan loading test as a function parameter in liver diseases].
Because of its specific hepatic degradation tryptophan was orally administered (50 mg/kg) to patients with various chronic liver diseases (n = 30) and to healthy volunteers (n = 8) as a test for hepatic function. The plasma half life of tryptophan was determined between 4 and 8 h after the amino acid load. It was found that in patients with cirrhosis (n = 25) the half life of tryptophan was prolonged to 4.7 +/- 0.4 h (means +/- SD), compared to 2.0 +/- 0.1 h in the controls. The tryptophan half life also correlated with the plasma concentration of albumin, bilirubin, cholinesterase and prothrombin time in these patients. In addition a significant correlation was observed with the galactose elimination capacity and the 45 min retention of BSP. Thus, the oral tryptophan loading test may be suitable for a more specific determination of functional impairment of the liver in chronic liver disease. In decompensated cirrhotic patients alterations of the tryptophan metabolism seen to be related to indicators of hepatic encephalopathy. The test may therefore be used to assess the degree and risk of hepatic encephalopathy in such patients.
D000328:Adult; D000368:Aged; D005690:Galactose / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D008099:Liver / Q000378:metabolism / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D008111:Liver Function Tests / Q000379:methods; D008875:Middle Aged; D013448:Sulfobromophthalein / Q000378:metabolism; D014364:Tryptophan / Q000097:blood / Q000378:metabolism
D013448:Sulfobromophthalein; D014364:Tryptophan; D005690:Galactose
Der Tryptophan-Belastungstest als Funktionsparameter bei Lebererkrankungen.